AzTrials
AzTrials

Carotid Plaque StabilityNCT04928547

An Integrated System for the Assessment of Carotid Plaque Stability Based on the Artificial Intelligence

An observational study of Carotid Plaque Stability, run by Second Affiliated Hospital, Zhejiang University, School of Medicine.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The project will be properly embedded in the clinical practice landscape to both provide a real-world context for research requirements gathering and research result assessment, and a practical application context from the industrial perspective. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Carotid Plaque Stability
What is being tested?
Test
How many people
100 participants
Where
No sites listed yet
Study dates
15 Jul 2021to 15 Jul 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Adult, Older adult

Study population: According to previous research and experience, the percentage of neovascularization grade II and above accounted for about 79% of all plaques in the enrolled patients, neovascularization grade I accounted for 21%, neovascularization grade II predicted the recurrence of stroke in the same basin 10%, neovascularization I The recurrence rate of stroke in the same watershed below grade is 6%, and the sample size is calculated to be about 100 cases. Gray-scale ultrasound shows the presence or absence of hypoechoic and iso-echoic, calcified nodules and other characteristics. The loss to follow-up rate is calculated as 10-15%. This study intends to include 2000 patients with acute anterior circulation ischemic stroke. A total of 100 patients were enrolled in this research center.

Who may be able to join

  • Age is greater than or equal to 18 years old and less than or equal to 80 years old;
  • At least one imaging examination suggests the presence of carotid artery plaque;
  • No allergy and other contraindications to ultrasound contrast;
  • Contrast-enhanced ultrasound examination of carotid artery plaque is required;
  • Volunteer to join this research project and sign informed consent.

Who cannot join

  • Patients who are unable to coordinate their body position or hold their breath during the ultrasound examination;
  • Patients with severe lack of clinical data;
  • During the follow-up, use drugs for the treatment of carotid plaque except lipid-lowering drugs, antiplatelet drugs, antioxidants, and calcium channel blockers;
  • Follow up those who have lost contact;
  • Ischemic stroke caused by non-carotid artery plaque shedding;
  • Patients with atrial fibrillation and other serious heart diseases;
  • A history of allergy to ultrasound contrast agents.

About this study

The project will be properly embedded in the clinical practice landscape to both provide a real-world context for research requirements gathering and research result assessment, and a practical application context from the industrial perspective. The landing is planned for cardiology solutions as carotid plaque assessment that can be value-adding features to tackle the current challenges of stroke prediction. The development of stroke prediction model could accelerate the R\&D process and land to key market ultrasound prototypes/products in an agile way. Collaboration and alignment with key market business and R\&D (China Digital Innovation CDI) through workshops and hackathons will be a unique feature of this agile project.

Read the detailed description

Stroke is a global disease with high mortality and disability. Evaluation of the stability of carotid plaque has important clinical significance for stroke prevention.

As a practical, fast, non-invasive, non-radiative inspection technique, ultrasound is widely used in the evaluation of carotid plaque stability. There are many methods for evaluating the stability of carotid plaque by ultrasound. The texture features extracted from two-dimensional ultrasound images can be used to quantify subtle differences in follow up scanning. The elastography of the plaques can be used to quantify changes in the elastic properties of reactive plaques. Contrast enhanced ultrasound (CEUS) can be used to quantify the density of microvessels. However, the results obtained by these different methods are biased and show poor agreement. We lack a unified, systematic evaluation system and objective guideline for plaque stability assessment. In this context, the topic of plaque stability assessment has been intensively explored by researchers from all over the world. Based on state-of-the-art assessment, we found that some plaques that were judged stable on ultrasound did eventually rupture. On the contrary, some unstable plaques on ultrasound did not cause stroke. This confusion indicates that plaque rupture is not only related to its intrinsic characteristics, such as size, shape, composition etc., but also to external factors such as biomechanics, strain, flow field, etc.. In order to achieve a better understanding of the pathological plaque behaviour, it is necessary to study the hemodynamic problems in the arteries, such as wall shear stress, flow separation, and secondary flow. The recent rapid developments in artificial-intelligence techniques have been widely used in medical imaging and image analysis. These techniques allow supervised learning taking full advantage of the available big data. Therefore, the main purpose of this study is to use artificial intelligence technique to i) evaluate a number of indicators including plaque histology, hemodynamics, etc., ii) establish a uniform and quantitative criteria for judging the stability of carotid plaque.

The key scientific problem to be solved in this project is to establish an objective model for predicting the risk of carotid plaque rupture for clinical decisionmaking.

It can be mainly divided into three main modules: database establishment, model training and clinical validation.

  1. Database establishment
  2. Obtaining clinical information of the patients from the electronic medical record system.
  3. Use of image analysis techniques in ultrasound images to study the relationship between different image texture parameters and plaque histological composition. A method for evaluating the stability of carotid plaque based on texture parameters will be established.
  4. Use of ultrasound (shear-wave) elastography to establish a method for assessing the carotid-plaque vulnerability based on the assessment of tissue elasticity.
  5. Combining carotid velocity vector imaging with the blood-flow vortex manipulation technique to achieve an accurate measurement of the central position of the vulnerable plaque blood flow vortex and the orbital angular momentum, providing a new technique for vulnerable plaque detection based on vortex vector blood flow. Block detection new technology. The biomechanical characteristics of arterial plaques will be evaluated by detecting the synchrony and coordination of the arterial wall. The relationship between the biomechanical characteristics and stability of different types of plaques in the cardiac cycle will also be investigated.
  6. Use of quantitative CEUS analysis and localization microscopy to study the relationship between CEUS and neovascularization in carotid plaques, focusing on the influence of microvessel density, architecture, and other quantitative features extracted from CEUS. Based on these features, a prediction model for plaque rupture will be designed and evaluated.
  7. Use of computational fluid dynamics modeling to study the effects of geometrical changes on local hemodynamics and blood component concentration distribution during plaque growth. Further analysis of the growth mechanism of plaque and its effect on hemodynamics will be made.
  8. Deep-learning model After obtaining all the parameters mentioned above, the correlation between these parameters and carotid plaque stability will be studied through machine learning.

A machine-learning classifier will be designed that takes the extracted features as input. Feature selection will be implemented through k-fold cross-validation to identify the set of complementary features that most contribute to assess plaque stability and predict plaque rupture. In particular, we aim at predicting whether a stroke will occur within 1 year. When sufficient data is available, a deep convolutional neural network will also be designed and trained to learn the prediction model. In this process, the risk of overfitting will be carefully considered by evaluating the classification performance over training, test, and validation sets.

As a result, the model complexity will be adjusted to the available training sets.

  1. clinical evaluation The validation of the developed stroke prediction model from rupture of carotid plaques will be extended to a number of hospitals. The model reliability and usability will be tested. Model update and improvement is envisaged in a cyclic fashion, profiting from clinical results and feedback. The accuracy rate auxiliary decision support is expected to levels that are not lower than 90%.
Being tested
Test

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TestDiagnostic test

    Different test

Study groups in NCT04928547
Study groupRoleWhat they receive
U.S.Not described
Receives: Diagnostic Test: Test
MRINot described
Receives: Diagnostic Test: Test

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Stroke

    Measured: 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jun 2021
  2. Study start15 Jul 2021 (estimated)
  3. Primary completion15 Jul 2021 (estimated)
  4. Study completion15 Jul 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04928547
Sponsor's protocol ID
2020-460-1
Status last verified
Jun 2021
First submitted
14 Jun 2021
Last updated
16 Jun 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Carotid Plaque Stability, run by Second Affiliated Hospital, Zhejiang University, School of Medicine.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Stroke (time frame: 3 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jun 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in